Text Size

Immediate Maintained Cannulation of a Newly Implanted Prosthetic Arteriovenous Access for Acute Hemodialysis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2008 by Far Eastern Memorial Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT00711750
First received: July 7, 2008
Last updated: July 8, 2008
Last verified: July 2008
History of Changes
  Purpose

Objectives: Examine the acute utility of immediate maintained cannulations of a newly implanted prosthetic arteriovenous access. Background: Recurrent failure of central catheterization is not uncommon. An alternative access is necessary for acute hemodialysis after the exhaustion of central veins. Methods: We constructed the access by cannulating two dialysis needle-catheters and securing them on the skin after the implantation of the graft. The access was used immediately and maintained for one week and thereafter used as a long-term access.


Condition
End-Stage Renal Disease
Prosthetic Arteriovenous Access

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Far Eastern Memorial Hospital:

Estimated Enrollment: 39
Study Start Date: January 2008
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with end-stage renal disease underwent the specific prosthetic arteriovenous access creation in our hospital from November 2003 to October 2005 were retrospectively reviewed.

Criteria

Inclusion Criteria:

  • end-stage renal disease underwent the specific prosthetic arteriovenous access creation in our hospital from November 2003 to October 2005

Exclusion Criteria:

  • patients' poor health as long as they did not have other options and needed an access for acute hemodialysis. Exclusions included shock, active systemic infection, and rejection by the attending nephrologists
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00711750

Contacts
Contact: Chih-Yang Chan, MD, PhD 886-89667000 chanchihyang@mail.femh.org.tw

Locations
Taiwan
Far Eastern Memorial Hospital Recruiting
Taipei, Taiwan
Contact: Chih-Yang Chan, MD, PhD     886-89667000     chanchihyang@mail.femh.org.tw    
Sponsors and Collaborators
Far Eastern Memorial Hospital
  More Information

No publications provided

Responsible Party: Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT00711750     History of Changes
Other Study ID Numbers: FEMH-96042
Study First Received: July 7, 2008
Last Updated: July 8, 2008
Health Authority: Taiwan: Department of Health

Keywords provided by Far Eastern Memorial Hospital:
underwent
specific
creation
 hospital
November 2003
October 2005

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency, Chronic
Renal Insufficiency

ClinicalTrials.gov processed this record on May 23, 2013